The Short Answer
Watchful waiting (annual PSA + DRE, no pills) is the standard first-line approach for asymptomatic N40.2. Only start medication if you develop urinary symptoms (weak stream, hesitation, nocturia) or PSA rises rapidly [1].
Federal trial data shows that men with asymptomatic nodular prostate (IPSS score 0–7) who undergo watchful waiting have the same long-term outcomes as men who start preventive medications—no difference in cancer risk, symptom development, or survival [1]. The landmark REDUCE trial found that finasteride (a 5-alpha reductase inhibitor) reduced prostate cancer risk by 25%, but it also caused sexual side effects in 10–15% of men. For asymptomatic men, the benefit doesn't outweigh the risk.
Your prostate's biology is stable right now: the nodules aren't blocking urine flow, your bladder empties completely, and your PSA is in the safe zone. Starting a daily pill when you feel fine is like taking blood pressure medication when your BP is 120/80. It's unnecessary and exposes you to side effects (erectile dysfunction, reduced ejaculate volume, gynecomastia) without proven benefit [1].
The practical trade-off is time and attention, not money or side effects. You'll spend 30 minutes per year on office visits and PSA labs ($150–300 annually). If PSA velocity accelerates or you develop hesitation or weak stream, that's when your urologist will prescribe tamsulosin (alpha-blocker, $30–50/month generic) or finasteride ($20–40/month generic). Most men never reach that point [1].
Try This Today
At your next visit, ask your urologist: 'What's my PSA velocity over the last 2–3 years?' If it's stable (<0.5 ng/mL per year), you're in the safest watchful-waiting zone. If it's creeping up (0.5–0.75 ng/mL per year), discuss a 6-month recheck instead of waiting a full year.